CA2144780A1 - Benzenesulfonamide derivatives - Google Patents

Benzenesulfonamide derivatives

Info

Publication number
CA2144780A1
CA2144780A1 CA002144780A CA2144780A CA2144780A1 CA 2144780 A1 CA2144780 A1 CA 2144780A1 CA 002144780 A CA002144780 A CA 002144780A CA 2144780 A CA2144780 A CA 2144780A CA 2144780 A1 CA2144780 A1 CA 2144780A1
Authority
CA
Canada
Prior art keywords
phenyl
methyl
butyrate
chlorophenylsulfonylamino
butyric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002144780A
Other languages
English (en)
French (fr)
Inventor
Yasuo Ito
Hideo Kato
Shingo Yasuda
Nobuo Ogawa
Shunichiro Sakurai
Tomio Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Japan Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2144780A1 publication Critical patent/CA2144780A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002144780A 1992-10-01 1993-09-29 Benzenesulfonamide derivatives Abandoned CA2144780A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP28493892 1992-10-01
JP4-284938 1992-10-01
JP5-165041 1993-06-11
JP16504193 1993-06-11

Publications (1)

Publication Number Publication Date
CA2144780A1 true CA2144780A1 (en) 1994-04-14

Family

ID=26489927

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002144780A Abandoned CA2144780A1 (en) 1992-10-01 1993-09-29 Benzenesulfonamide derivatives

Country Status (8)

Country Link
US (1) US5597848A (en, 2012)
EP (1) EP0663392A4 (en, 2012)
JP (1) JPH0753505A (en, 2012)
KR (1) KR950703522A (en, 2012)
AU (1) AU4833993A (en, 2012)
CA (1) CA2144780A1 (en, 2012)
TW (1) TW245638B (en, 2012)
WO (1) WO1994007848A1 (en, 2012)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0948775A (ja) * 1995-06-02 1997-02-18 Hokuriku Seiyaku Co Ltd (2−チエニル)アルカン酸誘導体
JPH10195038A (ja) * 1996-11-13 1998-07-28 Hokuriku Seiyaku Co Ltd ベンゼンスルホンアミド誘導体及びそれを含有する医薬
ATE218854T1 (de) * 1997-01-31 2002-06-15 Univ Leland Stanford Junior Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin- abhängigen protein kinase
FR2827280B1 (fr) * 2001-07-13 2003-10-31 Servier Lab Nouveaux derives de benzene sulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2003244913A1 (en) * 2002-07-09 2004-01-23 B.M.R.A. Corporation B.V. Pharmaceutical combination of a thromboxane A2 receptor antagonist and a COX-2 inhibitor
JP2007508242A (ja) * 2003-08-07 2007-04-05 ビー.エム.アール.エイ. コーポレイション ベスローテン フェンノートシャップ トロンボキサンa2受容体アンタゴニストとシクロオキシゲネーゼ−1の阻害剤との組み合わせを伴う組成物および方法
ITMI20061297A1 (it) * 2006-07-04 2008-01-05 Laboratorio Chimico Int Spa Procedimento per la preparazione della'acido (r)-(-)-3-(carbamoilmetil)-5-metilesanoico e del pregabalin e intermedi di sintesi
WO2009089098A1 (en) 2008-01-03 2009-07-16 Musc Foundation For Research Development Methods for the treatment of cancers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809377A1 (de) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3535167A1 (de) * 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel
DE3821540A1 (de) * 1988-06-25 1989-12-28 Boehringer Mannheim Gmbh Neue sulfonamide, verfahren zu ihrer herstellung sowie solche sulfonamide enthaltende arzneimittel
DE3829455A1 (de) * 1988-08-31 1990-03-15 Boehringer Mannheim Gmbh Sulfonamidoalkyl-cyclohexan-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel

Also Published As

Publication number Publication date
EP0663392A1 (en) 1995-07-19
WO1994007848A1 (en) 1994-04-14
EP0663392A4 (en) 1995-09-13
JPH0753505A (ja) 1995-02-28
US5597848A (en) 1997-01-28
TW245638B (en, 2012) 1995-04-21
AU4833993A (en) 1994-04-26
KR950703522A (ko) 1995-09-20

Similar Documents

Publication Publication Date Title
DE69108363T2 (de) Peptidylderivate.
KR100688740B1 (ko) 프로테아제 억제제로서의 n-시아노메틸 아미드
TW200904805A (en) Antibacterial agents
EP2649045A2 (de) Substituierte 1-benzylcycloalkylcarbonsäuren und ihre verwendung
MXPA02002873A (es) Compuestos y composiciones farmaceuticas como inhibidores de la catepsina s.
CA2456420A1 (en) Novel cyclohexyl sulphones
DE3826439A1 (de) Sulfonamidothienylcarbonsaeureverbindungen
NZ270009A (en) Glutamic acid derivatives and pharmaceutical compositions
AU2004287586A1 (en) Phosphinic acids derivatives, beta-secretase inhibitors for the treatment of Alzheimer's disease
CN103857655B (zh) 用于抑制11β-羟基类固醇脱氢酶1的化合物及包含该化合物的药物组合物
MXPA05005977A (es) Derivados de (2-amino-fenil)-amida del acido arilen-carboxilico como agentes farmaceuticos.
CA2144780A1 (en) Benzenesulfonamide derivatives
PL209113B1 (pl) Cykloheksylosulfony, zawierająca je kompozycja farmaceutyczna i zastosowanie związków
CA2584610A1 (en) Novel dicarboxylic acid derivatives
FR2664269A1 (fr) Nouveaux derives n-substitues d'alpha-mercapto alkylamines, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant.
JPH02306947A (ja) キラルβ―アミノ酸の製造方法
AU716395B2 (en) Benzenesulfonamide derivatives and medicaments comprising said derivatives
IE63162B1 (en) 5-substituted ornithine derivatives
JPH10502050A (ja) 骨関節疾患の治療に有用なn−〔{4,5−ジヒドロキシ−及び4,5,8−トリヒドロキシ−9,10−ジヒドロ−9,10−ジオキソ−2−アントラセン−イル}カルボニル〕アミノ酸
EP0005192B1 (de) Alkylaminopropanolderivate von 3-Alkyl-5-(2-hydroxystyryl)-isoxazolen, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel
NL1028559C2 (nl) Verbindingen die bruikbaar zijn voor de behandeling van ziekten
MXPA99004391A (en) Benzenesulfonamide derivatives and drugs containing the same
EA010133B1 (ru) Производные формамида, пригодные в качестве адренорецептора
SI9210090A (sl) Substituirani hidroksikarbamoilmetil- ali substituirani hidroksifosfonilmetil- derivati n-/4-metilvaleril/,3-metil-l-valinamida
AU2002312357A1 (en) Novel compounds and compositions as cathepsin inhibitors

Legal Events

Date Code Title Description
FZDE Dead